Pituitary resistance to thyroid hormones: Pathophysiology and therapeutic options

Endocrine

Volumn 40, Issue 3, 2011, Pages 366-371

  Suzuki, Satoru ^a   Shigematsu, Satoshi ^a   Inaba, Hidefumi ^a   Takei, Masahiro ^a   Takeda, Teiji ^a   Komatsu, Mitsuhisa ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Deiodinase; GRH; Propylthiouracil; PRTH; SITSH

Indexed keywords

BROMOCRIPTINE; CYTOSINE; LEVOTHYROXINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 14; PROPYLTHIOURACIL; THIAMAZOLE; THYMINE; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA2; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG; ANTITHYROID AGENT;

ADULT; AMINO ACID SUBSTITUTION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DIO2 GENE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE MUTATION; GOITER; GRAVES DISEASE; HEART PALPITATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; LOADING DRUG DOSE; MALE; MCT8 GENE; MEDICAL DECISION MAKING; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NUCLEAR MAGNETIC RESONANCE IMAGING; OATP14 GENE; PATHOPHYSIOLOGY; PITUITARY RESISTANCE TO THYROID HORMONE; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; TACHYCARDIA; THYROID FUNCTION TEST; THYROID HORMONE RELEASE; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; TRBETA2 GENE; TREATMENT OUTCOME; BLOOD; FEEDBACK SYSTEM; HYPOPHYSIS; HYPOPHYSIS DISEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PHYSIOLOGY; THYROID GLAND;

ANTITHYROID AGENTS; FEEDBACK, PHYSIOLOGICAL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY DISEASES; PITUITARY GLAND; PROPYLTHIOURACIL; THYROID GLAND; THYROID HORMONES; THYROTOXICOSIS; THYROTROPIN;

EID: 84858787274     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9538-2     Document Type: Review

References (36)

1. S. Refetoff, The syndrome of resistance to thyroid hormone. Endocr. Rev. 14, 348-399 (1993)
2. M.C. Gershengorn, B.D. Weintraub, Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". J. Clin. Invest. 56, 633-642 (1975)
3. R.E. Weiss, S. Refetoff, Resistance to thyroid hormone. Rev. Endocr. Metab. Disord. 1, 97-108 (2000)
4. S.Y. Cheng, J.L. Leonard, P.J. Davis, Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139-170 (2010)
5. T. Tagami, T. Usui, A. Shimatsu, M. Beniko, H. Yamamoto, K. Moriyama, M. Naruse, Aberrant expression of thyroid hormone receptor b isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma. J. Clin. Endocrinol. Metab. 96, 948-952 (2011)
6. M.I. Chiamolera, F.E. Wondisford, Minireview: thyrotropinreleasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150, 1091-1096 (2009)
7. E.D. Abel, H.C. Kaulbach, A. Campos-Barros, R.S. Ahima, M.E. Boers, K. Hashimoto, D. Forrest, F.E. Wondisford, Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotorphin. J. Clin. Invest. 103, 271-279 (1999) (Pubitemid 29053145)
8. E. Mihály, C. Fekete, G. Légrádi, R.M. Lechan, Hypothalamic dorsomedial nucleus neurons innervate thyrotorpin-releasing hormone-synthesizing neurons in the paraventricular nucleus. Brain Res. 891, 20-31 (2001) (Pubitemid 32115492)
9. S. Lee, B.M. Young, W. Wan, I.H. Chan, M.L. Privalsky, A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)b2. J. Mol. Endocrinol. 25, 1111-1125 (2011)
10. A.M. Dumitrescu, X.H. Liao, T.B. Best, K. Brockmann, S. Refetoff, A novel syndrome combing thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Human Genet. 74, 168-175 (2004) (Pubitemid 38085248)
11. M. Trajkovitc, T.J. Visser, J. Mittag, S. Horn, J. Lukas, V.M. Darras, G. Raivich, K. Bauer, H. Heuer, Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J. Clin. Invest. 117, 627-635 (2007) (Pubitemid 46348521)
12. H.M. Tu, S.W. Kim, D. Salvatore, T. Bartha, G. Legradi, P.R. Larsen, R.M. Lechan, Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138, 3359-3368 (1997) (Pubitemid 27345689)
13. R.P. Peeters, A.W. van den Beld, H. Attalki, H. Toor, Y.B. de Rijke, G.G. Kuiper, S.W. Lamberts, J.A. Janssen, A.G. Uitterlinden, T.J. Visser, A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. AM. J. Physiol. Endocrinol. Metab. 289, E75-E81 (2005) (Pubitemid 40874937)
14. M.J. Schneider, S.N. Fiering, S.E. Pallud, A.F. Parlow, D.L. Germain, V.A. Galton, Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 5, 2137-2148 (2001) (Pubitemid 33141133)
15. JSNP database http://snp.ims.u-tokyo.ac.jp
16. H.G. Sorensen, W.M. van der Deure, P.S. Hansen, R.P. Peeters, M.M. Breteler, K.O. Kyvik, T.I. Sorensen, L. Hegedus, T.J. Visser, Identification and consequences of polymorphisms in the thyroid hormone receptor alpha and beta genes. Thyroid 18, 1087-1094 (2008)
17. P. Beck-Peccoz, L. Persani, D. Calebiro, M. Bonomi, D. Mannavola, I. Campi, Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best. Pract. Res. Clin. Endocrinol. Metab. 20, 529-546 (2006) (Pubitemid 44856490)
18. P. Beck-Peccoz, G. Piscatelli, M.G. Cattaneo, G. Faglia, Successful treatment of hyperthyroidism due to non-neoplastic pituitary TSH hyperthyroidism with 3, 5, 37-triiodothyroacetic acid (TRIAC). J. Endocrinol. Invest. 6, 217-223 (1983) (Pubitemid 13031824)
19. J.M. Kunitake, N. Hartman, L.C. Henson, J. Lieberman, D.E. Williams, M. Wong, J.M. Hershman, 3, 5, 3'-triiodothyroacetic acid therapy for thyroid hormone resistance. J. Clin. Endocrinol. Metab. 69, 461-466 (1989) (Pubitemid 19208480)
20. M. Aquilar Diosdado, L. Escobar-Jimenez, M.L. Fermenez Soto, A. Garcia Curie, F. Escobar-Jimenez, Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3'triiodothyroacetic associated to propranolol. J. Endocrinol. Invest. 14, 663-668 (1991)
21. P.A. Schueler, H.L. Schwartz, K.A. Strait, C.N. Mariash, J.H. Oppenheimer, Binding of 3, 5, 3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the a- and b-forms for the acetic acid analog and failure of the human testis and kidney a-2 products to bind T3. Mol. Endocrinol. 4, 227-234 (1990)
22. T. Takeda, S. Suzuki, R.T. Liu, L.J. DeGroot, Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 80, 2033-2040 (1995)
23. F. Darendeliler, F. Bas, Successful therapy with 3, 5, 3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone. J. Pediatr. Endocrinol. Metab. 10, 535-538 (1997) (Pubitemid 27494386)
24. G. Radetti, L. Persani, G. Molinaro, D. Mannavola, D. Corteiazzi, V.K. Chaterjee, P. Beck-Peccoz, Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 7, 775-778 (1997) (Pubitemid 28086211)
25. D.R. Bajorunas, W. Rosner, I.A. Kourides, Use of bromocriptine in a patient with generalized resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 58, 731-735 (1984) (Pubitemid 14137271)
26. P.I. Salmela, L. Wilde, H. Juustila, A. Ruokonèn, Effects of thyroid hormones (T4, T3), bromocriptine, and TRIAC on inappropriate TSH hypersecretion. Clin. Endocrinol. 28, 497-507 (1988)
27. A.J. Dulgeroff, M.E. Geffner, S.N. Koyal, M. Wong, J.M. Hershman, Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 75, 1071-1075 (1992)
28. P. Hamon, M. Bovier-Lapierre, M. Robert, D. Peynaud, M. Pugeat, J. Orgiazzi, Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy. J. Clin. Endocrinol. Metab. 67, 1089-1093 (1988)
29. F. Dorey, G. Strauch, J.P. Gayno, Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D thyroxine: a study in three patients. Clin. Endocrinol. 32, 221-228
30. I.D. Schwartz, B.B. Bercu, Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor. Thyroid 2, 15-19 (1992)
31. J. Pohlenz, D. Knöbl, Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy. Acta Paediatr. 85, 387-390 (1996) (Pubitemid 26106202)
32. B. Hamon, P. Hamon, M. Bovier-Lapierre, M. Pugeat, F. Savagner, P. Rodien, J. Orgiazzi, A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up. Thyroid 18, 35-44 (2008) (Pubitemid 351170442)
33. T. Guran, S. Turan, R. Bircan, A. Bereket, 9 years follow-up of a patient with pituitary resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC). J. Pediatr. Endocrinol. Metab. 22, 971-978 (2009)
34. S. Refetoff, Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat. Clin. Pract. Endocrinol. Metab. 93, 605-610 (2008)
35. J. Bernal, Thyroid hormone resistance syndrome. Endocrinol. Nutr. 58, 185-196 (2011)
36. T.J. Visser, M.M. Kaplan, J.L. Leonard, P.R. Larsen, Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J. Clin. Invest. 71, 992-1002 (1983) (1990) (Pubitemid 13163272)